The Deal
Wednesday, November 25, 
6:09 pm

Entries tagged "Fresenius"

The Deal Calendar: Aug. 11-15, 2008

This week's episode of The Deal Calendar goes back to school. The Deal's Mary Kathleen Flynn speaks with The Deal's senior writer Matt Miller about the student loan crisis. The layers of lending have led to consolidation in the sector. ...


Deal activity heats up while markets look for some footing

Monday began with a rush of deal activity, pushing the markets slightly into the green. German pharmaceutical company Fresenius SE agreed to pay up to $5.6 billion including debt for APP Pharmaceuticals Inc., while General Electrical Co. through a subsidiary added the Weather Channel. Meanwhile, all forecasts show that Merrill Lynch & Co. is moving closer to selling its stake in financial publisher Bloomberg LP and is weighing the sale of its stake in BlackRock Inc. Behind all this activity, the Dow went on a roller-coaster ride, gaining in the morning but giving up 110.23, or 0.89%, by the early...


Fresenius to acquire APP for up to $5.6B

Healthcare group Fresenius SE finally secured a U.S. foothold for its intravenous drugs business with an agreed offer for APP Pharmaceuticals Inc. worth as much as $5.6 billion in cash and debt. ...



Top tags

You have executed a tag search on Dealscape. On the left,you will find a comprehensive list of stories tagged "Fresenius." Below are the most-popular tags for Dealscape. On the right of the page you will find a search box to dig deeper into our content.
The Deal Pipeline

Deal Video


Inside The Deal: AlixPartners' Steve Deedy on Black Friday, the holiday season and retail bankruptcies.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

REIT IPO deja vu

Real estate sponsors that might wish to undertake an IPO will need to consider a wide variety of issues and begin to take action long before the first filing with the SEC.


Industry Insight

Loan-to-buy

Paulson's proposal to purchase an equity stake in Yellow Pages publisher Idearc is the second time in recent months an investor group has used its prepetition debt position to execute a bargain price 'exit LBO.'


Industry Insight

Managing your shareholder base

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.